Golden State Medical Supply Inc. FDA Record
Golden State Medical Supply Inc. has 55 FDA recalls (1 Class I), 10 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Golden State Medical Supply Inc., the most recent on Apr 26, 2011.
- Latest recall
- D-0847-2026 · Class II · Aug 21, 2026
- Latest inspection
- Jun 11, 2025 · NAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 55 (1 Class I) | Nov 8, 2026 | File dated Nov 3, 2026 | Current |
| 510(k) clearances | 0 | Nov 8, 2026 | File dated Nov 2, 2026 | Current |
| Inspections | 10 | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 1 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 5 | 0 |
| 2025 | 1 | 0 | 0 | 3 | 0 |
| 2024 | 0 | 0 | 0 | 3 | 0 |
| 2023 | 0 | 0 | 0 | 4 | 0 |
| 2022 | 0 | 0 | 0 | 8 | 1 |
| 2021 | 0 | 0 | 0 | 3 | 0 |
| 2020 | 0 | 0 | 0 | 4 | 0 |
| 2019 | 1 | 0 | 0 | 11 | 0 |
| 2018 | 0 | 0 | 0 | 3 | 0 |
| 2017 | 1 | 0 | 0 | 0 | 0 |
Reviewing Golden State Medical Supply Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Golden State Medical Supply Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Golden State Medical Supply Inc. FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Apr 26, 2011 · Record page |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0847-2026 | Class II | Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated… | Aug 21, 2026 |
| D-0771-2026 | Class II | Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count… | Aug 7, 2026 |
| D-0587-2026 | Class II | GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured… | May 29, 2026 |
| D-0535-2026 | Class III | Primidone Tablets, USP, 250 mg, 100-count bottle, RX only, Manufactured by: Lannett Company, Inc… | Apr 27, 2026 |
| D-0534-2026 | Class III | Primidone Tablets, USP, 50 mg, 50-count bottle, RX only, Manufactured by: Lannett Company, Inc… | Apr 27, 2026 |
| D-0235-2026 | Class II | Baclofen Tablets USP, 10 mg, 1000-count bottles, Rx only, Marketed by: GSMS, Incorporated, CA 93012… | Nov 26, 2025 |
| D-0158-2026 | Class II | NIACIN Extended-Release Tablets, USP, 1,000 mg, 90 tablets per bottle, Rx only, Manufactured by… | Oct 20, 2025 |
| D-0287-2025 | Class II | PRASUGREL TABLETS, 5 mg, 30 tablet bottles, Rx only, packaged by GSMS, Incorporated, Camarillo, CA… | Mar 5, 2025 |
| D-0568-2024 | Class II | Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, a) 30 capsules bottles, NDC 60429-165-30… | May 13, 2024 |
| D-0349-2024 | Class II | Fluticasone Propionate Nasal Spray USP, 50 mcg per spray, 120 metered sprays, 16 g net fill, Rx… | Feb 14, 2024 |
| D-0276-2024 | Class II | Budesonide Extended-Release Tablets, 9 mg, 30-count bottles, Rx only, Marketed by: GSMS… | Jan 12, 2024 |
| D-0129-2024 | Class II | PAROXETINE tablets, USP, 20 mg, Packaged as a) 90-count bottle NDC 60429-735-90; b)1000-count… | Nov 10, 2023 |
| D-0130-2024 | Class II | PAROXETINE tablets, USP, 40 mg, Packaged as a) 30-count bottle, NDC 60429-737-30; b) 90-count… | Nov 10, 2023 |
| D-0128-2024 | Class II | PAROXETINE tablets, USP, 10 mg, Packaged as a) 30-count bottle, NDC 60429-734-30; b) 90-count… | Nov 10, 2023 |
| D-0867-2023 | Class II | Travoprost Ophthalmic Solution, USP (Ionic Buffered Solution), 0.004%, Rx only, Manufactured by… | May 25, 2023 |
| D-0011-2023 | Class II | Rifampin Capsules, USP, 300 mg, packaged in a) 30-count bottle (NDC 51407-323-30), b) 60-count… | Oct 6, 2022 |
| D-0012-2023 | Class II | Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Manufactured by Patheon Pharmaceuticals… | Oct 6, 2022 |
| D-0019-2023 | Class I | Atenolol Tablets, USP, 25 mg, 1000-count bottle, Rx only, Manufactured by: ALPHAPHARM PTY LTD… | Sep 29, 2022 |
| D-1180-2022 | Class II | Enalapril Maleate Tablets, USP; 20 mg; 90 tablets, NDC 60429-186-90; manufactured by Taro… | Mar 16, 2022 |
| D-1179-2022 | Class II | Enalapril Maleate Tablets, USP; 10 mg; 90 tablets, NDC 60429-185-90; manufactured by Taro… | Mar 16, 2022 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Jun 11, 2025 | Camarillo, CA | Drugs | No Action Indicated (NAI) | 3006458969 |
| Aug 16, 2019 | Camarillo, CA | Drugs | No Action Indicated (NAI) | 3006458969 |
| Apr 6, 2017 | Camarillo, CA | Drugs | No Action Indicated (NAI) | 3006458969 |
| May 16, 2013 | Camarillo, CA | Drugs | Voluntary Action Indicated (VAI) | 3006458969 |
| Jul 26, 2012 | Camarillo, CA | Drugs | Voluntary Action Indicated (VAI) | 3006458969 |
| Aug 16, 2011 | Camarillo, CA | Drugs | Voluntary Action Indicated (VAI) | 3006458969 |
| Feb 2, 2011 | Camarillo, CA | Drugs | Official Action Indicated (OAI) | 3006458969 |
| Dec 15, 2010 | Camarillo, CA | Drugs | Voluntary Action Indicated (VAI) | 3006458969 |
| May 13, 2009 | Camarillo, CA | Drugs | No Action Indicated (NAI) | 3006458969 |
| Feb 26, 2009 | Camarillo, CA | Drugs | No Action Indicated (NAI) | 3006458969 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 1 compliance action under Golden State Medical Supply Inc.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3006458969 | Camarillo, CA | 10 | Jun 11, 2025 |
Golden State Medical Supply Inc. and the FDA: common questions
Has Golden State Medical Supply Inc. received an FDA warning letter?
Yes. FDA has issued 1 warning letter to Golden State Medical Supply Inc.. The most recent is dated Apr 26, 2011.
Has Golden State Medical Supply Inc. received an FDA Form 483?
FDA has not published a Form 483 for "Golden State Medical Supply Inc." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Golden State Medical Supply Inc.?
The most recent FDA inspection on file ended Jun 11, 2025 at Camarillo, CA and was classified NAI. FDA has 10 inspections of Golden State Medical Supply Inc. on file, 1 of them classified OAI (official action indicated).
Has Golden State Medical Supply Inc. had an FDA recall?
Yes. Golden State Medical Supply Inc. has 55 FDA recalls on record, 1 of them Class I, the most serious class. The most recent started Aug 21, 2026.
Need more than this page shows? Ask about Golden State Medical Supply Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.